GST Council Proposes Reforms to Expedite Refunds and Clarify Export Definitions
The GST Council is considering reforms to support exporters and pharmaceutical companies by legally backing 90% of inverted duty refund claims, allowing faster GST refunds on services and machinery, and redefining export status for services through overseas branches. Proposals include treating clinical trials and contract manufacturing for foreign clients as exports, permitting input tax credit on free samples and expired medicines, and extending exemptions for imported medicines for rare diseases. These changes aim to improve liquidity, reduce tax burdens, and clarify export definitions across sectors.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (65/100). Lens Score 41/100.
Outlets measured: thefinancialexpress, economictimes, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (58–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 5 Oct, 12:22 pm. Other outlets followed.